TherapeuticsMD operates as a women's health care product company. The Company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. TherapeuticsMD creates products to address the unique changes and challenges women experience through every stage of their lives.
Type
Public
HQ
Boca Raton, US
Founded
2008
Size (employees)
159 (est)
TherapeuticsMD was founded in 2008 and is headquartered in Boca Raton, US
Report incorrect company information

Key People/Management at TherapeuticsMD

Robert Finizio

Robert Finizio

Chief Executive Officer
Dan Cartwright

Dan Cartwright

Chief Financial Officer
John Milligan

John Milligan

President
Julia Amadio

Julia Amadio

Chief Product Officer
Brian Bernick

Brian Bernick

Co-founder & Chief Clinical Officer
Mitchell Krassan

Mitchell Krassan

Chief Strategy Performance Officer

TherapeuticsMD Office Locations

TherapeuticsMD has an office in Boca Raton
Boca Raton, US (HQ)
6800 Broken Sound Pkwy NW
Show all (1)
Report incorrect company information

TherapeuticsMD Financials and Metrics

TherapeuticsMD Financials

TherapeuticsMD's revenue was reported to be $19.36 m in FY, 2016 which is a 3.9% decrease from the previous period.
USD

Revenue (Q2, 2017)

4.3 m

Gross profit (Q2, 2017)

3.6 m

Gross profit margin (Q2, 2017), %

84%

Net income (Q2, 2017)

(19.7 m)

EBIT (Q2, 2017)

(19.8 m)

Market capitalization (25-Apr-2018)

1.1 b

Cash (30-Jun-2017)

96.5 m
TherapeuticsMD's current market capitalization is $1.1 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

8.8 m15 m20.1 m19.4 m

Revenue growth, %

71%34%(4%)

Cost of goods sold

2 m3.7 m4.5 m4.2 m

Gross profit

6.8 m11.4 m15.6 m15.2 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

2.3 m2.8 m3.8 m4.2 m4.5 m4.8 m5.2 m4.9 m4.4 m5.5 m4 m4.3 m

Cost of goods sold

648.4 k830.7 k893 k1.1 m1 m1 m1.2 m1.1 m1.1 m1.2 m659.6 k681.7 k

Gross profit

1.6 m2 m2.9 m3.1 m3.4 m3.8 m4 m3.8 m3.3 m4.3 m3.3 m3.6 m

Gross profit Margin, %

72%71%76%74%77%79%77%78%74%78%83%84%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

54.2 m51.4 m64.7 m131.5 m

Inventories

1 m1.2 m690.2 k1.1 m

Current Assets

59.4 m56.2 m70.7 m139.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

59.6 m45.4 m35.6 m67 m67.2 m81.1 m182.1 m166.5 m147.5 m113.5 m96.5 m

Inventories

1.1 m920.7 k1.5 m1 m1.2 m870.1 k957.4 k883.7 k843.4 k1.3 m1.4 m

Current Assets

65.9 m51 m41.8 m72.2 m73 m87.8 m189.8 m174 m156.1 m121.3 m103.5 m

Total Assets

68.5 m53.6 m44.4 m74.6 m75.7 m90.5 m193 m176.6 m158.8 m124.4 m106.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.4 m)(54.2 m)(85.1 m)(89.9 m)

Depreciation and Amortization

58.1 k52.5 k62.4 k132.5 k

Inventories

571.6 k(138.5 k)492 k(386.2 k)

Accounts Payable

472.9 k4.2 m(3.2 m)4.2 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(7.7 m)(9.2 m)(10.9 m)(17.8 m)(20.9 m)(48.1 m)(67.6 m)(20.9 m)(42 m)(67 m)(21.2 m)(40.8 m)

Depreciation and Amortization

32.4 k13.1 k14.1 k12.7 k13.6 k27.9 k44.4 k19.6 k24.3 k40.5 k49.7 k

Inventories

1.5 m1 m222.9 k(66.6 k)312.1 k(267.3 k)(193.5 k)(153.2 k)(262.3 k)(337.7 k)

Accounts Payable

2.3 m5.6 m(91.9 k)(508.5 k)(1 m)304.5 k(86.8 k)1.1 m(1.2 m)749.5 k
USDY, 2017

Financial Leverage

1.1 x
Show all financial metrics
Report incorrect company information